A Modern Pharmaceutical Leader

Who are we

 Our aim is simple: to positively impact lives, together. Using the power of science and innovation, our people improve the impact medicine has on patients. Together, we explore the limitless world of science through our impressive product pipeline and we take our understanding of many therapeutic areas to a whole new level by seeking new treatments.
With such essential, life-changing work being undertaken across the world, the range of roles we offer is extensive. From Regulatory and Medical Affairs to Finance, Manufacturing, and Supply, our opportunities cover many disciplines. Here, you can explore the full potential of science while building a career that means more to you and our patients.

OTDP Pharmaceuticals

We are OTDP Pharmaceuticals, one of the world’s most forward-thinking and connected Pharmaceutical companies. With a strong purpose, an even stronger bond between each of our people, and a science-led, patient-first attitude, we’re changing the future of medicine and the impact it can have on lives across the globe.  Are you ready for a challenge?

0
Countries
0
Offieces
0
Manufaturing Facilities

Our Marketplace

The global pharmaceuticals market is vast. The Middle East remains a priority market for growth with other key growth areas including emerging markets and Asia Pacific regions.

This trend of increasing demand is expected to continue as the world’s population grows, economies in the emerging markets become more prosperous, and global changes in lifestyles affect long-term health.

Our strategy​

Our strategy is to research and produce innovative, high-quality, and needed medicines; making these as accessible as possible to countries at all levels of income and development. To do this we focus on creating a strong differentiated pipeline, leading in Nervous and respiratory, and developing our presence in specialty therapy areas The journey to discovering and developing new medicines is lengthy, expensive, and subject to a high rate of failure. Learn more about our research and development.

We are exploring different approaches to promote – and speed up – innovation in our labs. Having broken down the traditional, R&D model, our scientists now work in smaller units focused on specific areas of research. This encourages greater entrepreneurialism and accountability. These groups are tasked with seeking out the biological targets involved in disease and creating molecules or biopharmaceuticals that will ultimately become new medicines.

We also know that we won’t discover everything inside our own labs and that we need to partner with other companies, academic institutions, and research charities. We currently have research collaborations with more than 127 external organizations.

Our Purpose

We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world. We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.

That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow

Our Credo

Our strategy is to research and produce innovative, high-quality, and needed medicines; making these as accessible as possible to countries at all levels of income and development. To do this we focus on creating a strong differentiated pipeline, leading in Nervous and respiratory, and developing our presence in specialty therapy areas The journey to discovering and developing new medicines is lengthy, expensive, and subject to a high rate of failure. Learn more about our research and development.

We are exploring different approaches to promote – and speed up – innovation in our labs. Having broken down the traditional, R&D model, our scientists now work in smaller units focused on specific areas of research. This encourages greater entrepreneurialism and accountability. These groups are tasked with seeking out the biological targets involved in disease and creating molecules or biopharmaceuticals that will ultimately become new medicines.

We also know that we won’t discover everything inside our own labs and that we need to partner with other companies, academic institutions, and research charities. We currently have research collaborations with more than 127 external organizations.

We are responsible to the communities in which we live and work and to the world community as well. We must help people be healthier by supporting better access and care in more places around the world. We must be good citizens — support good works and charities, better health and education, and bear our fair share of taxes. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources

Our final responsibility is to our stockholders. Business must make a sound profit. We must experiment with new ideas. Research must be carried on, innovative programs developed, investments made for the future and mistakes paid for. New equipment must be purchased, new facilities provided and new products launched. Reserves must be created to provide for adverse times. When we operate according to these principles, the stockholders should realize a fair return.